Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aytu Biopharma (AYTU) Enterprise Value: 2009-2025

Historic Enterprise Value for Aytu Biopharma (AYTU) over the last 17 years, with Jun 2025 value amounting to -$17.5 million.

  • Aytu Biopharma's Enterprise Value fell 147.37% to -$14.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$83.5 million, marking a year-over-year decrease of 28.58%. This contributed to the annual value of -$17.5 million for FY2025, which is 367.07% down from last year.
  • Aytu Biopharma's Enterprise Value amounted to -$17.5 million in FY2025, which was down 367.07% from -$3.7 million recorded in FY2024.
  • In the past 5 years, Aytu Biopharma's Enterprise Value registered a high of $76.0 million during FY2021, and its lowest value of -$17.5 million during FY2025.
  • Over the past 3 years, Aytu Biopharma's median Enterprise Value value was -$16.9 million (recorded in 2023), while the average stood at -$12.7 million.
  • As far as peak fluctuations go, Aytu Biopharma's Enterprise Value surged by 77.88% in 2024, and later crashed by 367.07% in 2025.
  • Aytu Biopharma's Enterprise Value (MRY) stood at $76.0 million in 2021, then tumbled by 90.45% to $7.3 million in 2022, then tumbled by 333.40% to -$16.9 million in 2023, then skyrocketed by 77.88% to -$3.7 million in 2024, then tumbled by 367.07% to -$17.5 million in 2025.
  • Its last three reported values are -$17.5 million in FY2025, -$3.7 million for FY2024, and -$16.9 million during FY2023.